WST
USDWest Pharmaceutical Services Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$278.380
Kõrge
$287.875
Madal
$277.195
Maht
0.41M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
20.6B
Tööstusharu
Medical Instruments & Supplies
Riik
United States
Kauplemisstatistika
Keskmine maht
0.64M
Börs
NYQ
Valuuta
USD
52 nädala vahemik
Seotud uudised
TD Cowen Initiates Coverage On West Pharmaceutical Servs with Buy Rating, Announces Price Target of $350
TD Cowen analyst Brendan Smith initiates coverage on West Pharmaceutical Servs with a Buy rating and announces Price Target of $350.
Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325
Barclays analyst Luke Sergott maintains West Pharmaceutical Servs with a Equal-Weight and raises the price target from $275 to $325.
West Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
UBS Maintains Buy on West Pharmaceutical Servs, Raises Price Target to $355
UBS analyst John Sourbeer maintains West Pharmaceutical Servs with a Buy and raises the price target from $320 to $355.
Keybanc Maintains Overweight on West Pharmaceutical Servs, Raises Price Target to $350
Keybanc analyst Paul Knight maintains West Pharmaceutical Servs with a Overweight and raises the price target from $325 to $350.
West to Participate in Upcoming Investor Conferences
West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
Evercore ISI Group Maintains Outperform on West Pharmaceutical Servs, Raises Price Target to $390
Evercore ISI Group analyst Daniel Markowitz maintains West Pharmaceutical Servs with a Outperform and raises the price target from $350 to $390.
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.